About this trial
The primary aim of this study is to evaluate the effectiveness of multimodal brain monitoring technologies as both an early warning system and a prognostic tool in patients suffering from acute brain injuries. This research seeks to determine how effectively these tools can predict clinical outcomes and prevent complications by providing early alerts to healthcare professionals.
Eligibility criteria
Qualifiers
Must be 18 years of age or older.
Diagnosed with Traumatic Brain Injury (TBI) or has suffered from acute brain injury due to intracranial hemorrhage or subarachnoid hemorrhage.
Defined as an admission Glasgow Coma Scale (GCS) Eye Response score of 1 (unable to open eyes) and a GCS Motor Response score of ≤5 (unable to obey commands).
Occurs within 48 hours of admission, where the patient does not open eyes and motor score drops to 5 or below.
Disqualifiers
Patients who were not admitted to the Intensive Care Unit (ICU) are excluded.
Patients with forms of acute brain injury other than those specified (TBI, intracranial hemorrhage, subarachnoid hemorrhage) are also excluded.
Patients with known severe liver or kidney dysfunction are excluded.
Patients whose vital signs are extremely unstable after admission, with a very poor prognosis and considered unable to survive, and whose family has decided to forgo further treatment.
Trial design
Treatments tested in this trial
- no intervention